This newsletter is a part of our 2023 Stakeholders’ Series. Through this channel you’ll get industry, program, and IHA-wide insights, in a more tailored and timely way.
The final MY 2023 AMP Technical Specifications and the preliminary MY 2023 AMP Program Guide are now available on IHA.org. Please download these documents from our AMP Participant Resources under the AMP Program Guide and Technical Specifications section.
View MY 2022-2023 standard value-based incentive design methodology
IHA’s Program Governance Committee has made recommendations for the MY 2022 and 2023 incentive design methodology.
These recommendations include:
Returning to the standard value-based incentive design methodology for MY 2022-2023
Introducing a few enhancements, including higher Quality Gate, recalibrated Quality Multiplier (shared risk incentive design only), and updated Total Cost of Care Adjuster (full risk incentive design only).
For MY 2022 only, the Advancing Care Information domain will be excluded when calculating Quality Composite Scores (QCS) for AMP Commercial HMO POs due to recent CMS suppression. This means a PO may earn up to 60 points for its performance on clinical quality measures and up to 30 points for its performance on patient experience measures, culminating in a maximum QCS of 90 points.
Save your spot! IHA’s Health Policy Update is June 20
Don’t forget to register for IHA’s first Health Policy Update webinar!
During the webinar, thought leaders will share updates on key legislative and regulatory activities, California’s new Office of Health Care Affordability, and work underway to improve provider directories.
The webinar is part of IHA’s 2023 Stakeholders’ Series.
The preview period for updates to the 2022–2023 Edition Health Care Quality Report Cards — Commercial and Medicare is scheduled to begin in mid-June.
Prior to the preview period, organizations will be sent a link to access the OPA Stakeholder page. To be added to OPA’s mailing list, send an email to OPAReportCard@ncqa.org.
IHA partners with the California Office of the Patient Advocate (OPA) to publicly report AMP Commercial HMO and Medicare Advantage performance results each year. The report cards highlight overall performance and individual quality results for select clinical topics. Commercial report cards also include patient experience and total cost of care results.
AMP Technical FAQ Updated — MY 2023 Onpoint Data Submission Guide
The AMP Technical FAQ provides guidance for common questions about data submission. We’ve recently made updates to include MY 2023 Onpoint Data Submission Guide reporting clarifications for the following fields:
ME203 - Assigned Primary Care Provider
ME212, TC004, MI007 - Accountable Care Organization Identifier (ACO)
PC003 - Insurance Type/ Product Code
Get ready for your upcoming MY 2023 submissions to Onpoint and review the updated AMP Technical FAQ.
in the pipeline
Webinar: Transition to ECDS-only reporting: Breast Cancer Screening
NCQA is hosting a webinar on the Breast Cancer Screening (BCS) measure’s transition to the exclusive use of the Electonic Clinical Data Systems (ECDS) reporting for MY 2023. Last year, IHA and NCQA hosted a three-part technical training series which provided an introduction to ECDS reporting. AMP participants are encouraged to review these presentations in preparation for this summer's webinar.
As a reminder, AMP participants will need to purchase the BCS-E digital measure package which is included in the MY 2023 AMP Digital Measure Bundle on the NCQA Store Page.
